Zhejin Pharma's Hong Kong IPO Prospectus Expires After 6 Months

According to Zhitong Finance, Zhejin Pharma (688266.SH) Hong Kong IPO prospectus expired on June 19, 2026, six months after submission on December 19, 2025. China International Capital Corporation served as the sole sponsor.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments